http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2726314-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7b78226fd9f51c2807c71b8e6d243433 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-02 |
| filingDate | 2019-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c2d4d473c9cb492ea2573fbef8806de http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_419d8b5f259ada2bdd4b34641c666c9d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1229a8e234e9c7a99d392cca4f091967 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_634d57c7b770606e0965aa259e771cd2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f91a1f10890629990ccadcc5029e9ec |
| publicationDate | 2020-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2726314-C1 |
| titleOfInvention | Method for early prediction of acute renal injury in patients with coronary heart disease following myocardial revascularization by coronary artery bypass grafting |
| abstract | FIELD: medicine. n SUBSTANCE: invention refers to medicine, namely to medical diagnostics, and can be used for early prediction of the risk of acute renal injury in patients with ischemic heart disease following myocardial revascularization by coronary artery bypass grafting. Level of MMP-8 and TIMP-1 in blood serum is determined by enzyme-linked immunosorbent assay. If the MMP-8 level is more than 1.4 ng/ml in the preoperative period and more than 1.1 ng/ml on 1 st postoperative day, concentration of its TIMP-1 inhibitor lower than 221.1 ng/ml before CABG and below 230.3 ng/ml after it, high risk of renal complications following aortocoronary bypass is determined. n EFFECT: method enables early prediction of the risk of acute renal injury in the patients with coronary artery disease following CHD by determining reliable criteria for the risk of acute renal injury in the patients with CHD after coronary artery bypass grafting, namely: increase of MMP-8 level and decrease of TIMP-1 in blood serum before CABG and then on the first postoperative day, which enables to predict the risk of renal complications in a short period of time and to adopt the necessary strategy of therapy of the given pathological condition. n 1 cl, 1 tbl, 2 dwg, 2 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2765678-C1 |
| priorityDate | 2019-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 80.